Aortic Valve Bioprosthesis

The Carpentier-Edwards PERIMOUNT Magna Ease aortic valve is part of the proven family of PERIMOUNT surgical valves.

Backed by over 20 years of published clinical studies for proven longevity and demonstrated hemodynamic stability, the Carpentier-Edwards PERIMOUNT Magna Ease aortic valve combines a tested design with the benefits of pericardial tissue to deliver the potential for on-going durability.

Proven PERIMOUNT valve design

Mathematically modeled, bioengineered design

Optimized for hemodynamics, durability and implantability

Flexible cobalt-chromium alloy stent

Absorbs energy to reduce leaflet stress

Three independent bovine pericardial leaflets

Matched for thickness and elasticity to optimize stress distribution

After more than 1 billion cycles, the Magna Ease valve still performed like new14

The Magna Ease valves demonstrated excellent durability after the equivalent of 25 years in simulated in vitro wear, with hydrodynamic performance similar to that of a new valve.

Clinical studies show excellent long-term durability

More long-term clinical study publications than any other bioprosthetic aortic valve.

Ease of implant

The PERIMOUNT Magna Ease valve offers many key design features that enhance the valve’s ease of implant.

Specifications

Indications

The Carpentier-Edwards PERIMOUNT Magna Ease pericardial bioprosthesis is intended for use in patients whose aortic valvular disease is sufficiently advanced to warrant replacement of their natural valve with a prosthetic one. It is also intended for use in patients with a previously implanted aortic valve prosthesis that is no longer functioning adequately and requires replacement.